학술논문

Cost-effectiveness of active case-finding of household contacts of pulmonary tuberculosis patients in a low HIV, tuberculosis-endemic urban area of Lima, Peru
Document Type
article
Source
Epidemiology and Infection. 145(6)
Subject
Medical Microbiology
Biomedical and Clinical Sciences
Rare Diseases
Clinical Research
Comparative Effectiveness Research
Emerging Infectious Diseases
Cost Effectiveness Research
Tuberculosis
Infectious Diseases
HIV/AIDS
Infection
Good Health and Well Being
Cost-Benefit Analysis
Diagnostic Tests
Routine
Endemic Diseases
Family Characteristics
HIV Infections
Humans
Mass Screening
Peru
Tuberculosis
Pulmonary
Case-finding
community epidemics
cost-effectiveness
public health
tuberculosis
Public Health and Health Services
Epidemiology
Veterinary sciences
Clinical sciences
Language
Abstract
We compared the cost-effectiveness (CE) of an active case-finding (ACF) programme for household contacts of tuberculosis (TB) cases enrolled in first-line treatment to routine passive case-finding (PCF) within an established national TB programme in Peru. Decision analysis was used to model detection of TB in household contacts through: (1) self-report of symptomatic cases for evaluation (PCF), (2) a provider-initiated ACF programme, (3) addition of an Xpert MTB/RIF diagnostic test for a single sputum sample from household contacts, and (4) all strategies combined. CE was calculated as the incremental cost-effectiveness ratio (ICER) in terms of US dollars per disability-adjusted life years (DALYs) averted. Compared to PCF alone, ACF for household contacts resulted in an ICER of $2155 per DALY averted. The addition of the Xpert MTB/RIF diagnostic test resulted in an ICER of $3275 per DALY averted within a PCF programme and $3399 per DALY averted when an ACF programme was included. Provider-initiated ACF of household contacts in an urban setting of Lima, Peru can be highly cost-effective, even including costs to seek out contacts and perform an Xpert/MTB RIF test. ACF including Xpert MTB/RIF was not cost-effective if TB cases detected had high rates of default from treatment or poor outcomes.